Antimalarials (Formulary)

Up-to-date information on malaria prophylaxis is available from http://www.travax.scot.nhs.uk/ or from Medicine Information. For guidance on prescribing medicines for travel refer to Guidance on prescribing vaccines and medicines for travel.

CHLOROQUINE

Important: Therapy notes

MHRA advice: Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions (February 2022) (www.gov.uk).

Important: Formulation and dosage details

Formulation:

Tablets 250mg^OTC (Protected antibiotic to be prescribed on the advice of an infection specialist only)

ARTESUNATE

Important: Therapy notes

Preferred choice in severe malaria; for further information see UK malaria treatment guidelines 2016.
See NICE Malaria scenario management.

Important: Formulation and dosage details

Formulation:

Injection 60mg unlicensed (Protected antibiotic to be prescribed on the advice of an infection specialist only)

ARTEMETHER WITH LUMEFANTRINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets (artemether 20mg, lumefantrine 120mg) (Riamet^®) (Protected antibiotic to be prescribed on the advice of an infection specialist only)

CHLOROQUINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

ARTESUNATE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

ARTEMETHER WITH LUMEFANTRINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Editorial Information